Pernille Lassen

Summary

Affiliation: Aarhus University Hospital
Country: Denmark

Publications

  1. ncbi request reprint Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark Electronic address
    Radiother Oncol 113:310-6. 2014
  2. ncbi request reprint Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    J Clin Oncol 27:1992-8. 2009
  3. ncbi request reprint HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    Radiother Oncol 94:30-5. 2010
  4. ncbi request reprint The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, DK 8000 Aarhus C, Denmark
    Radiother Oncol 95:371-80. 2010
  5. ncbi request reprint The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 100:49-55. 2011
  6. ncbi request reprint Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
    Kasper Toustrup
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arahus C, Denmark
    Radiother Oncol 102:122-9. 2012
  7. ncbi request reprint FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial
    Lise Saksø Mortensen
    Aarhus University Hospital, Denmark
    Radiother Oncol 105:14-20. 2012
  8. ncbi request reprint Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 50:1006-14. 2011
  9. ncbi request reprint Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 108:489-94. 2013

Detail Information

Publications9

  1. ncbi request reprint Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark Electronic address
    Radiother Oncol 113:310-6. 2014
    ....
  2. ncbi request reprint Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    J Clin Oncol 27:1992-8. 2009
    ....
  3. ncbi request reprint HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Noerrebrogade 44, DK 8000 Aarhus C, Denmark
    Radiother Oncol 94:30-5. 2010
    ..Using p16-status as a retrospective stratification parameter, we aimed to assess the influence of p16-expression on the response to nimorazole in HNSCC...
  4. ncbi request reprint The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, DK 8000 Aarhus C, Denmark
    Radiother Oncol 95:371-80. 2010
    ..This review provides a summary of the current understanding of the role of HPV in head and neck cancer with specific focus on the viral impact on radiotherapy outcome of HNSCC...
  5. ncbi request reprint The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 100:49-55. 2011
    ..We aimed to assess the influence of tumour HPV-status, expressed by p16, on the response to accelerated fractionated radiotherapy in HNSCC through evaluation of the DAHANCA 6&7 trial...
  6. ncbi request reprint Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck
    Kasper Toustrup
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Arahus C, Denmark
    Radiother Oncol 102:122-9. 2012
    ..To validate the predictive impact of a hypoxia gene expression classifier in identifying patients with head and neck squamous cell carcinoma (HNSCC) having benefit from hypoxic modification of radiotherapy...
  7. ncbi request reprint FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial
    Lise Saksø Mortensen
    Aarhus University Hospital, Denmark
    Radiother Oncol 105:14-20. 2012
    ..The purpose of this study was to evaluate (18)F-fluoroazomycin arabinoside (FAZA) positron emission tomography (PET)/computed tomography (CT) hypoxia imaging as a prognostic factor in HNSCC patients receiving radiotherapy...
  8. ncbi request reprint Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Camilla Molich Hoff
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Acta Oncol 50:1006-14. 2011
    ..Aim of the current analysis was to gain additional power by adding patients from the continued subrandomization in the DAHANCA 7 trial, now including a total of almost 1200 patients...
  9. ncbi request reprint Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials
    Pernille Lassen
    Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
    Radiother Oncol 108:489-94. 2013
    ..The aim was to investigate the correlation and interaction between these two markers and to evaluate their potential prognostic significance when combined...